Attitudes and approaches to vaginal atrophy in postmenopausal women: A focus group qualitative study

Climacteric

Volumn 17, Issue 1, 2014, Pages 29-36

  Utian, W H ^a,c   Maamari, R ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NOVO NORDISK INC   (United States)

^c Point East P7 ^*  (United States)

Author keywords

COUNSELING; PERSONALITY; POSTMENOPAUSAL WOMEN; SYMPTOMS; TREATMENT; VAGINAL ATROPHY

Indexed keywords

LUBRICATING AGENT;

ADULT; AGED; AGING; ARTICLE; ATTITUDE TO ILLNESS; COPING BEHAVIOR; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PATIENT COUNSELING; PERSONALITY; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; STRESS; SYMPTOMATOLOGY; VAGINA ATROPHY; VERY ELDERLY;

AGING; ATROPHY; ATTITUDE OF HEALTH PERSONNEL; COUNSELING; DYSPAREUNIA; ESTROGENS; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LUBRICANTS; PERSONALITY; POSTMENOPAUSE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; VAGINA; VAGINAL DISEASES; WOMEN'S HEALTH;

EID: 84892760423     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2013.850480     Document Type: Article

References (21)

1. C M , R eher D , A lcala L C , P rice K. T he menopause in Spain: results of the DAMES (Decisions At MEnopause) study. Maturitas 2005 ; 52 : 190-8
2. Bachmann GA , Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 2000 ; 61 : 3090-6
3. Mac Bride M B , R hodes D J, S huster L T. V ulvovaginal atrophy. Mayo Clin Proc 2010 ; 85 : 87-94
4. Santoro N , K omi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med 2009 ; 6 : 2133-42
5. Simon J A , K omi J. V ulvovaginal atrophy (VVA) negatively impacts sexual function, psychosocial well-being, and partner relationships. Presented at The North American Menopause Society (NAMS), Dallas, Texas , October 3-6 , 2007
6. Nappi R E, K okot-Kierepa M. V aginal Health: Insights, Views & Attitudes (VIVA)-results from an international survey. Climacteric 2012 ; 15 : 36-44
7. Cumming G P , H erald J , M oncur R , C urrie H , L ee A J. W omen?s attitudes to hormone replacement therapy, alternative therapy and sexual health: a web-based survey. Menopause Int 2007 ; 13 : 79-83
8. Nappi RE , Kokot-Kierepa M. Women?s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas 2010 ; 67 : 233-8
9. Wyeth. REVEAL REvealing Vaginal Effects At mid-Life: Surveys of postmenopausal women and health care professionals who treat postmenopausal women. May 2009 ; http:// www.revealsurvey.com/pdf/reveal-survey-results.pdf. Accessed April 6, 2012
10. Geeroms N. Towards a better understanding of motivational consumer behavior: Cross-validation, construct validation and application of a psychological taxonomy of consumer motives. Belgium, Ghent University , 2007
11. Sturdee DW , Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010 ; 13 : 509-22
12. The North American Menopause Society. T he role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 2007 ; 14 : 357-69
13. Nappi R E , K ingsberg S , M aamari R , S imon J. T he CLOSER (CLarifying Vaginal Atrophy?s Impact On SEx and Relationships) Survey: Implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med 2013 ; 10 : 2232-41
14. Simon JA , Nappi RE , Kingsberg SA , Maamari R , Brown V. Clarifying Vaginal Atrophy?s Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners. Menopause 2013 June 3 ; Epub ahead of print
15. Bachmann G A , L eiblum S R , G rill J. B rief sexual inquiry in gynecologic practice. Obstet Gynecol 1989 ; 73 : 425-7
16. Archer DF. Effi cacy and tolerability of local estrogen therapy for urogenital atrophy. Menopause 2010 ; 17 : 194-203
17. Rees M , Perez-Lopez FR, C easu I , et al. EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy. Maturitas 2012 ; 73 : 171-4
18. Eriksen PS , Rasmussen H. Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study. Eur J Obstet Gynecol Reprod Biol 1992 ; 44 : 137-44
19. Casper F, Petri E. Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebocontrolled multicenter study. Vaginal Ring Study Group. Int Urogynecol J Pelvic Floor Dysfunct 1999 ; 10 : 171-6
20. Bygdeman M , Swahn ML. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas 1996 ; 23 : 259-63
21. Suckling J, Lethaby A , Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006(4) : CD001500